-
It is estimated that 10% of women worldwide are affected by
#Endometriosis | Our latest infographic looks at how we can find an effective treatment - https://hubs.ly/H0mT--X0#researchneverstops pic.twitter.com/Mad7xSoUps
-
Later this month our parent company
@Evotec will be in California at the 14th Annual Huntington's Disease Therapeutics Conference: A Forum for Drug Discovery & Development | https://hubs.ly/H0mS6pC0 | To arrange a meeting, get in contact - info@evotec.com#researchneverstops pic.twitter.com/Xt3VyTVhA7
-
Article download | 'Can biomarkers help us develop personalized medicines faster?' | Joanna Lisztwan, EVP and Head of Global In Vitro Biology | https://hubs.ly/H0mSVMz0
#researchneverstops pic.twitter.com/HOVjqoGr3v
-
Next week our parent comany
@Evotec will be at#BioInfect2020 | Antonio Felici, VP Anti-Infectives and Jens Glaeser, Principal Scientist will present | Arrange a meeting with our experts, contact us - info@evotec.com |@Bionow#researchneverstops pic.twitter.com/2YbkCMvcrk
-
Get up-to-date with what we've been up over the last month with our latest newsletter | https://hubs.ly/H0mRZzk0
#researchneverstops pic.twitter.com/d9wme52HzT
-
Get up-to-date with all things
@cyprotex with their latest newsletter | https://hubs.ly/H0mRP1R0#researchneverstops pic.twitter.com/fmARFAaglL
-
Next week we will be at
#TOW2020 | SVP Head of Oncology, Mark Whittaker and Operations colleagues will be on site to discuss your needs | Get in touch to arrange a meeting - info@evotec.com | More about the event here - https://hubs.ly/H0mMKB40#researchneverstops@tow_2020pic.twitter.com/chzG3HoScH
-
Article download - 'How does successful compound management influence drug development success?' - https://hubs.ly/H0mLR5v0 | info@evotec.com
#researchneverstops@Labiotech_eupic.twitter.com/oivG1X6OsY
-
@Evotec announced today that its partner@Bayer decided to advance a further programme from the#endometriosis multi-target alliance into clinical Phase I development. Read the full press release here https://hubs.ly/H0mPxCd0#researchneverstops pic.twitter.com/y3CtUm7XqZ
-
The
@Evotec UK Discovery Chemistry and a combined Aptuit Development and Evotec Discovery Chemistry team have reached the final of this year’s RSC/SCI National Retrosynthesis Competition. More here - https://hubs.ly/H0mMBwj0@SCIupdate#researchneverstops pic.twitter.com/6VdUeaZTPp
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
